Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-08-06FDA Approved: LORATADINE AND PSEUDOEPHEDRINE SULFATE — Original Application (DR REDDYS)
FDA approves original application for Loratadine and Pseudoephrine Sulfate combination product (ANDA 220448) from DR REDDYS.
-
FDA approval · 2026-07-30FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (DR REDDYS)
FDA approval information for the original application of fexofenadine hydrochloride (generic antihistamine) by Dr. Reddy's.
-
EMA approval · 2026-07-24EMA Authorised: Desloratadine Teva (desloratadine) — Teva B.V
Desloratadine Teva has been authorised by the EMA for allergic rhinitis (perennial and seasonal).
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Update: A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 [Phase 3]
Phase 3 trial update for a house dust mite SLIT-tablet in Chinese participants with allergic rhinitis/rhinoconjunctivitis is ongoing but not…
-
EMA approval · 2026-06-05EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome [Phase 1]
Phase 1 clinical trial evaluating the efficacy and safety of Yiqi Wenyang Sanhan Formula combined with acupoint application in patients with…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of the Adjunctive Effects of Moxibustion in the Treatment of Cold-Syndrome Allergic Rhinitis [NA]
This clinical trial assesses whether adjunctive moxibustion adds benefit to standard treatment for allergic rhinitis described as cold syndr…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: The Effect of Oral Probiotics on Allergic Rhinitis Symptoms and the Quality of Life [NA]
This clinical trial update notes an active, non-recruiting study evaluating the effect of an oral probiotic on allergic rhinitis symptoms an…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis [Phase 4]
This Phase 4 clinical trial compares adding an antihistamine or an antileukotriene to intranasal corticosteroid therapy for allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters
The clinical trial update notes that the longitudinal observational study assessing lung function in prematurely born preschool children wit…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Effects of Adenoidectomy on Symptoms and IgE Levels in Children With AR [NA]
Clinical trial update for a NOT_YET_RECRUITING study at Tongji Hospital assessing the impact of adenoidectomy (and tonsillectomy) on symptom…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
A completed clinical trial evaluating nasal biomarkers for objective assessment of disease severity in chronic respiratory diseases, includi…
-
EMA approval · 2026-04-07EMA Authorised: Aerinaze (desloratadine;pseudophedrine sulfate) — Organon N.V.
EMA authorized Aerinaze, a fixed-dose combination of desloratadine and pseudoephedrine sulfate, for allergic rhinitis with seasonal symptoms…
-
FDA approval · 2026-04-03FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's phenylephrine hydrochloride as an original ANDA, confirming a generic version of this decongest…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Dietary Intervention on Atopy [NA]
A dietary intervention trial for individuals with atopy, including atopic dermatitis and allergic rhinitis, is currently recruiting.
-
FDA approval · 2026-03-24FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC. This action confirms regulatory ap…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project [NA]
This clinical trial update describes evaluation of a digital tool called NavigAITme to improve adherence to aeroallergen immunotherapy in al…
-
EMA approval · 2026-03-19EMA Authorised: Neoclarityn (desloratadine) — Organon N.V.
The EMA authorised Neoclarityn (desloratadine) by Organon N.V. for allergic rhinitis (perennial and seasonal) and urticaria.
-
EMA approval · 2026-03-19EMA Authorised: Aerius (desloratadine) — Organon N.V.
The European Medicines Agency has authorised Aerius (desloratadine), a non-sedating antihistamine for allergic rhinitis (perennial and seaso…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Development and Validation of the Air Quality Awareness Scale (AQAS) for Parents
The completed trial reports development and validation of the Air Quality Awareness Scale (AQAS) for parents to assess knowledge, attitudes,…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children [NA]
Clinical trial update announcing a recruiting study at Antalya Training and Research Hospital to test whether an AI-based storytelling video…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma [Phase 1, Phase 2]
This clinical trial evaluates the safety and immunogenicity of cat-allergen intralymphatic immunotherapy in individuals with cat allergy, wi…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: LYmph Node eXamination in Cat Allergen Immunotherapy [EARLY_Phase 1]
An EARLY Phase 1 study led by NIAID investigating lymph node examination in cat allergen immunotherapy is listed as not yet recruiting. The …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
This clinical trial update reports a special drug use observational study of omalizumab (Xolair) in adolescents aged 12 to 17 with seasonal …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites [Phase 2]
Phase 2 trial evaluating sublingual immunotherapy for allergic rhinitis caused by house dust mites; the study is currently not yet recruitin…